Medigene AG
MDGEF · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $53,987 | $61,332 | $87,570 | $90,839 |
| - Cash | $14,024 | $8,674 | $16,550 | $22,224 |
| + Debt | $2,545 | $2,036 | $2,483 | $3,726 |
| Enterprise Value | $42,508 | $54,694 | $73,503 | $72,341 |
| Revenue | $4,476 | $2,970 | $3,064 | $5,963 |
| % Growth | 50.7% | -3.1% | -48.6% | – |
| Gross Profit | $3,703 | $2,249 | $2,142 | $4,795 |
| % Margin | 82.7% | 75.7% | 69.9% | 80.4% |
| EBITDA | -$5,937 | -$8,844 | -$6,702 | $17,385 |
| % Margin | -132.6% | -297.8% | -218.7% | 291.5% |
| Net Income | -$6,726 | -$9,207 | -$6,970 | -$22,249 |
| % Margin | -150.3% | -310% | -227.5% | -373.1% |
| EPS Diluted | -0.52 | -0.37 | -0.28 | -0.91 |
| % Growth | -40.5% | -32.1% | 69.2% | – |
| Operating Cash Flow | -$7,088 | -$7,085 | -$8,034 | -$5,326 |
| Capital Expenditures | -$302 | -$319 | -$345 | -$725 |
| Free Cash Flow | -$7,390 | -$7,404 | -$8,379 | -$6,051 |